ClinConnect ClinConnect Logo
Search / Trial NCT06207812

Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis

Launched by M.D. ANDERSON CANCER CENTER · Jan 5, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking into the long-term effects of two skin conditions called juvenile-onset mycosis fungoides and lymphomatoid papulosis in young patients. The goal is to follow up with individuals diagnosed with these conditions before they turned 20 years old. Researchers want to check on how these conditions have affected their lives over time, gathering insights directly from the participants or their parents if they are still minors.

To participate in this study, individuals must have been diagnosed with either of these conditions before the age of 20. If the participant is under 18, their parents will be contacted to help answer the study questions since the children themselves are not involved. This trial is currently recruiting participants of any gender, and it aims to understand the long-term outcomes for those who have lived with these skin disorders. Participants can expect to share their experiences and health status, contributing valuable information that may help others in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • -To be eligible, participants had to be diagnosed with jMF or lyp before age 20. In the case of participants below the age of 18, parents and not the children will be contacted for participation (children are exempt from participation as their parents may answer our study questions).
  • Exclusion Criteria:
  • -Participants older than 20 years of age at diagnosis

About M.D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center is a leading institution dedicated to cancer care, research, education, and prevention. As one of the world’s most respected cancer centers, MD Anderson focuses on innovative treatment approaches and groundbreaking clinical trials aimed at improving patient outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to advancing cancer research and providing comprehensive, personalized care to patients. MD Anderson's clinical trials play a pivotal role in translating scientific discoveries into effective therapies, positioning the center at the forefront of cancer treatment and research.

Locations

Houston, Texas, United States

Houston, Texas, United States

Patients applied

0 patients applied

Trial Officials

Julia Dai, MD

Principal Investigator

M.D. Anderson Cancer Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported